Pfizer Ltd. — Interim / Quarterly Report 2023

Nov 25, 2022

==> picture [100 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

November 25, 2022

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1st Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai – 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2022.

The said disclosure is also available on the website of the Company i.e., www.pfizerltd.co.in

Please take the above on record

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [98 x 19] intentionally omitted <==

----- Start of picture text -----

PRAJEET
----- End of picture text -----

NAIR

Digitally signed by PRAJEET NAIR DN: c=IN, o=Personal, 2.5.4.20=9933a48702916ad69ca05ea07b057e4a4737e501e6 5094b9d54663b70517bbe5, postalCode=400054, st=MAHARASHTRA, serialNumber=c24aea3eb0ba76c8cf19782a6242b9b35252d6 b9461f59c3998022881b762db1, cn=PRAJEET NAIR, l=MUMBAI, title=7345, pseudonym=734520210415120738822, email=PRAJEET.NAIR@PFIZER.COM Date: 2022.11.25 16:19:07 +05'30'

Prajeet Nair Director – Corporate Services & Company Secretary

Encl.: A/a

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in

Pfizer Limited - Statement of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015 for the half year ended September 30, 2022.

Sr. no	Details of the party listed entity entering into the transaction		Details of the counter party		Type of related party transaction	Value of the related party transaction as approved by the audit committee	Remarks on approval by Audit Committee	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction
	Name	PAN	Name	Relationship of the counterparty with the listed entity or its subsidiary					Opening balance	Closing balance
1	Pfizer Limited	AAACP3334M	Pfizer Service Company BVBA, Belgium	Fellow subsidiary	Purchase of goods or services	238.28	On arm's length basis and in Ordinary course of business	238.28	81.60	33.53
2	Pfizer Limited	AAACP3334M	Pfizer Healthcare India Private Limited	Fellow subsidiary	Service Income	1.97	On arm's length basis and in Ordinary course of business	1.97	5.74	-1.97
3	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	Fellow subsidiary	Service Income	9.14	On arm's length basis and in Ordinary course of business	9.14	-3.90	-10.02
4	Pfizer Limited	AAACP3334M	Pfizer Export B.V.	Fellow subsidiary	Service Income	0.32	On arm's length basis and in Ordinary course of business	0.32	-2.05	-0.32
5	Pfizer Limited	AAACP3334M	Pfizer Worldwide Services Company	Fellow subsidiary	Service Income	28.74	On arm's length basis and in Ordinary course of business	28.74	-13.03	-33.27
6	Pfizer Limited	AAACP3334M	Pfizer Corporation Hong Kong Limited	Fellow subsidiary	Re-imbursement of Expense	0.01	On arm's length basis and in Ordinary course of business	0.01	0.00	0.01
7	Pfizer Limited	AAACP3334M	Pfizer Overseas LLC	Fellow subsidiary	Inter Company Write Back	0.25	On arm's length basis and in Ordinary course of business	0.25	0.35	-
8	Pfizer Limited	AAACP3334M	Pfizer Products India Private Limited	Fellow subsidiary	Recovery of Expenses	0.17	On arm's length basis and in Ordinary course of business	0.17	-	-
9	Pfizer Limited	AAACP3334M	John Wyeth & Brother Ltd	Company collectively exercising significant influence	Dividend paid	5.73	On arm's length basis and in Ordinary course of business	5.73	2.44	2.50
10	Pfizer Limited	AAACP3334M	Parke, Davis & Company LLC	Fellow subsidiary	Dividend paid	6.21	On arm's length basis and in Ordinary course of business	6.21	-	-
11	Pfizer Limited	AAACP3334M	Pfizer East India BV	Fellow subsidiary	Dividend paid	118.21	On arm's length basis and in Ordinary course of business	118.21	-	-
12	Pfizer Limited	AAACP3334M	Pharmacia LLC	Fellow subsidiary	Dividend paid	5.10	On arm's length basis and in Ordinary course of business	5.10	-	-
13	Pfizer Limited	AAACP3334M	Warner-Lambert Company LLC	Fellow subsidiary	Dividend paid	7.72	On arm's length basis and in Ordinary course of business	7.72	-	-
14	Pfizer Limited	AAACP3334M	Wyeth Holdings LLC	Fellow subsidiary	Dividend paid	10.60	On arm's length basis and in Ordinary course of business	10.60	-	-
15	Pfizer Limited	AAACP3334M	Wyeth LLC	Fellow subsidiary	Dividend paid	36.52	On arm's length basis and in Ordinary course of business	36.52	-	-
20	Pfizer Limited	AAACP3334M	Mr. Pradip Shah	Independent Director	Sitting Fees	0.04	On arm's length basis and in Ordinary course of business	0.04	-	-

21	Pfizer Limited	AAACP3334M	Mr. Uday Khanna	Independent Director	Sitting Fees	0.03	On arm's length basis and in Ordinary course of business	0.03	-	-
22	Pfizer Limited	AAACP3334M	Mr. Sunil Lalbhai	Independent Director	Sitting Fees	0.03	On arm's length basis and in Ordinary course of business	0.03	-	-
23	Pfizer Limited	AAACP3334M	Ms. Meena Ganesh	Independent Director	Sitting Fees	0.02	On arm's length basis and in Ordinary course of business	0.02	-	-
16	Pfizer Limited	AAACP3334M	Mr. S. Sridhar	Key Managerial Personnel	Remuneration	4.13	On arm's length basis and in Ordinary course of business	4.13	-	-
17	Pfizer Limited	AAACP3334M	Mr. Milind Patil	Key Managerial Personnel	Remuneration	2.15	On arm's length basis and in Ordinary course of business	2.15	-	-
18	Pfizer Limited	AAACP3334M	Mr. Samir Kazi	Key Managerial Personnel	Remuneration	1.42	On arm's length basis and in Ordinary course of business	1.42	-	-
19	Pfizer Limited	AAACP3334M	Mr. Prajeet Nair	Key Managerial Personnel	Remuneration	0.40	On arm's length basis and in Ordinary course of business	0.40	-	-